Literature DB >> 26759458

Curing Metastatic Breast Cancer.

George W Sledge1.   

Abstract

Metastatic breast cancer is generally considered incurable, and this colors doctor-patient interactions for patients with metastatic disease. Although true for most patients, there appear to be important exceptions, instances where long-term disease-free survival occurs. Although these instances are few in number, they suggest the possibility of cure. How will we move toward cure for a much larger population of patients with metastatic disease? This article outlines a potential research agenda that might move us toward that distant goal.
Copyright © 2016 by American Society of Clinical Oncology.

Entities:  

Mesh:

Year:  2016        PMID: 26759458     DOI: 10.1200/JOP.2015.008953

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN: 1554-7477            Impact factor:   3.840


  29 in total

1.  Conquering Metastatic Breast Cancer.

Authors:  Nancy E Davidson
Journal:  J Oncol Pract       Date:  2016-01       Impact factor: 3.840

2.  Long-Term Survival of De Novo Stage IV Human Epidermal Growth Receptor 2 (HER2) Positive Breast Cancers Treated with HER2-Targeted Therapy.

Authors:  Yao Wong; Akshara Singareeka Raghavendra; Christos Hatzis; Javier Perez Irizarry; Teresita Vega; Nina Horowitz; Carlos H Barcenas; Mariana Chavez-MacGregor; Vicente Valero; Debu Tripathy; Lajos Pusztai; Rashmi K Murthy
Journal:  Oncologist       Date:  2018-08-23

3.  Fabrication and Characterization of Tumor Nano-Lysate as a Preventative Vaccine for Breast Cancer.

Authors:  Jenna A Dombroski; Nidhi Jyotsana; Davis W Crews; Zhenjiang Zhang; Michael R King
Journal:  Langmuir       Date:  2020-06-05       Impact factor: 3.882

4.  Beliefs and Perceptions About Cancer Diagnosis and Treatment-Seeking and Decision-Making Behaviors Among Omani Patients with Cancer: A Single-Center Study.

Authors:  Shiyam Kumar; Muna Al-Balushi; Philomena Charlotte Dsouza; Khalid Al-Baimani; Ikram A Burney; Mansour Al-Moundhri
Journal:  J Relig Health       Date:  2021-08-11

5.  Correlation between circulating tumor cells and different molecular biological characteristics in breast cancer patients.

Authors:  Min Zhou; Liping Jiang; Yiyi Fan; Tao Ma; Yan Wang; Xuzhen Wang
Journal:  Gland Surg       Date:  2022-02

6.  The LabBM score is an excellent survival prediction tool in patients undergoing palliative radiotherapy.

Authors:  Carsten Nieder; Astrid Dalhaug; Ellinor Haukland
Journal:  Rep Pract Oncol Radiother       Date:  2021-09-30

7.  Blocking CXCR4 alleviates desmoplasia, increases T-lymphocyte infiltration, and improves immunotherapy in metastatic breast cancer.

Authors:  Ivy X Chen; Vikash P Chauhan; Jessica Posada; Mei R Ng; Michelle W Wu; Pichet Adstamongkonkul; Peigen Huang; Neal Lindeman; Robert Langer; Rakesh K Jain
Journal:  Proc Natl Acad Sci U S A       Date:  2019-01-30       Impact factor: 11.205

8.  Tumour-Targeted and Redox-Responsive Mesoporous Silica Nanoparticles for Controlled Release of Doxorubicin and an siRNA Against Metastatic Breast Cancer.

Authors:  Jialang Zhuang; Siqi Chen; Ye Hu; Fan Yang; Qin Huo; Ni Xie
Journal:  Int J Nanomedicine       Date:  2021-03-08

9.  Local Treatment in Addition to Endocrine Therapy in Hormone Receptor-Positive and HER2-Negative Oligometastatic Breast Cancer Patients: A Retrospective Multicenter Analysis.

Authors:  Chihwan Cha; Sung Gwe Ahn; Tae-Kyung Yoo; Kun Min Kim; Soong June Bae; Changik Yoon; Soeun Park; Joohyuk Sohn; Joon Jeong
Journal:  Breast Care (Basel)       Date:  2019-10-29       Impact factor: 2.860

10.  Metastatic Breast Cancer as a Chronic Disease: Evidence-Based Data on a Theoretical Concept.

Authors:  Constanze Elfgen; Giacomo Montagna; Seraina Margaretha Schmid; Walter Bierbauer; Uwe Güth
Journal:  Breast Care (Basel)       Date:  2019-09-18       Impact factor: 2.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.